Introduction
Additionally, 40 % of SLE patients have anti-RNP antibodies, which specifically bind to the A, C and 70kD proteins within U1snRNPs 1 . It has been demonstrated that immune complexes containing nucleic acids can directly activate murine B lymphocytes and conventional DC as well as human plasmacytoid DC thus contributing to the development of full-blown SLE [2] [3] [4] . Type I interferon (IFN-α/-β), which is induced by SLE IC in vitro, is found at high levels in the serum of most patients with active SLE.
Microarray analysis in peripheral blood mononuclear cells of SLE patients revealed the typical "IFN-signature" of gene expression, which correlated with disease activity 5, 6 .
There is strong evidence for a central role of IFN-α/β in SLE pathogenesis from studies in the New Zealand Black (NZB)/New Zealand White (NZW) mouse model of lupus 7, 8 , whereas conflicting results were obtained in the Fas lpr mouse model of lupus-like disease only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From 9, 10 . The SLE-promoting role of IFN-α/β may be attributed to the support of B cell differentiation and antibody production 11, 12 , as well as to the induction of dendritic cell (DC) differentiation and maturation 13 . Plasmacytoid DC (PDC), which have been identified as the major source of IFN-α/β in SLE 14 are thought to be important players in this systemic autoimmune disorder 15, 16 . Apart from IFN-α, IL-6, which is produced by PDC and other cell types has also been implicated in the pathogenesis of SLE, because it induces plasma cell and effector T cell differentiation and blocks the activity of CD4+CD25+ regulatory T cells 17, 18 .
Altogether these data raise the question, which receptors are involved in the recognition of SLE IC. In a recent study DNA-containing IC isolated from sera of SLE patients or generated experimentally have been shown to trigger Toll-like receptor (TLR)-9 -the receptor for bacterial CpG DNA -in B lymphocytes and DC 4, 19, 20 . Activation of TLR9
by "self" DNA requires endosomal translocation. This is achieved by Fc receptor or B cell receptor mediated endocytosis of DNA-containing IC and can be mimicked by cationic lipid mediated transport 4, 20, 21 . Interestingly, TLR9-independent activation of myeloid DC by anti-nucleosome IC has also been observed 19 . This may be attributed to an as of yet unidentified DNA recognition mechanism or to additional stimulatory components within nucleosomes. A recent study found that IFN-α induction in PDC by complexes generated from necrotic cell material and SLE-IgG was sensitive to RNAse pretreatment 3 . Since snRNPs (specifically U1snRNP) are the major SLE autoantigens besides dsDNA, we investigated their stimulatory potential for murine PDC. In this study, we show that purified U1snRNP complexed with cationic lipid or anti-Sm 
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Cells were stained with anti-CD11b-FITC, anti-B220-APC and anti-CD86-PE (BD Biosciences, Heidelberg, Germany) and analysed on a FACS Calibur flow cytometer (BD Biosciences). Dead cells were excluded from analysis by gating on PI-negative cells. For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From with U1snRNP/Y12-Ab IC. Isolated PDC produced both IFN-α and IL-6 in response to U1snRNP IC, whereas isolated conventional DC produced high amounts of IL-6 but IFN-α was below the detection limit (Table 1) . Therefore both PDC and conventional DC within FL-DC are directly activated by U1snRNP IC, but PDC are the major source of IFN-α in response to U1snRNP IC.
U1snRNP triggers TLR7-dependent and -independent activation pathways
We hypothesized that U1snRNA could be responsible for the immunostimulatory effect For
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U1snRNP. FL-DC contain 40 to 50 % PDC, which have been shown to express TLR7 but not TLR3 and 40 to 50 % conventional DC which express TLR3 and in part also TLR7 32 . The role of TLR3 and TLR7 for recognition of U1snRNP was investigated by comparing cytokine production and CD86 upregulation of FL-DC derived from bone marrow cells of C57BL/6 wildtype, TLR3-/-and TLR7-/-mice in response to U1snRNP/DOTAP and U1snRNP/Y12-Ab IC ( Figure 5 ). Activation of FL-DC by U1snRNP-complexes was independent of TLR3 by all parameters measured, while the response to Poly I:C was mainly TLR3-mediated. IFN-α and IL-6 production by FL-DC in response to U1snRNP complexes were significantly reduced in the absence of TLR7 similar to the response to Poly U RNA, suggesting that recognition of U1RNA by TLR7 is mainly responsible for induction of IFN-α  and IL-6 by U1snRNP/Y12-Ab IC ( Figure   5A and B). However a small residual IFN-α and IL-6 response to U1snRNP as well as Poly U ssRNA was observed in TLR7-deficient FL-DC suggesting the presence of an additional recognition mechanisms for ssRNA in FL-DC. This was in contrast to the response to imidazoquinolin, which was entirely TLR7-mediated (data not shown). In contrast to IFN-α and IL-6 release RANTES and IL-12p40 production induced by U1snRNP and Poly U RNA were lower but not significantly reduced in the absence of TLR7 (data not shown). Upregulation of CD86 expression by U1snRNP was significantly lower but still present in TLR7-deficient cells as compared to WT and TLR3-/-cells (figure 5 C).
To verify that the U1snRNA within U1snRNP does indeed act as an endogenous ligand for TLR7 we tested the stimulatory capacity of U1snRNA isolated from U1snRNP as FcγRIIa, which is expressed in a subpopulation of PDC (CD32) 20, 33 . This receptor is not expressed in mice, but it has been shown in another study that murine myeloid DC required FcγRIII expression for activation by chromatin-IC 19 . FcγRI (CD64), which is also expressed in murine DC 36 and has been shown to bind murine IgG3-IC 37 , could be responsible for uptake of U1snRNP/Y12-ab IC in our study.
Pretreatment of FL-DC with IFN-β enhanced IFN-α production in response to U1snRNP complexes (figure 2 and 6) and the synthetic TLR7-ligand imidazoquinolin (data not shown) as has been previously described for human PDC stimulated with SLE-IgG plus apoptotic cells 30 . Despite constitutive expression of IRF-7 in PDC, efficient and sustained IFN-α production in PDC also strongly depends on the positive feedback loop of type I IFN which leads to IRF-7 upregulation as has been shown by Honda et al. 38 . In addition to IRF-7 induction, upregulation of TLR7 by type I IFN stimulation, which has been demonstrated for human B lymphocytes 39 may contribute to the observed enhancing effect of IFN-β.
Despite the important role of TLR7 for triggering the IFN-α and IL-6 response to U1snRNP in FL-DC, we observed a small residual production of these cytokines in the absence of TLR7. Additionally CD86 upregulation induced by U1snRNP was only partially TLR7-dependent ( figure 5 ) and the release of RANTES and IL-12p40 in response to U1snRNP complexes was only slightly but not significantly reduced in the only.
For Overall this study shows that TLR7 plays an essential role for IFN-α and IL-6 production by murine PDC and conventional DC in response to U1snRNP autoantigen. We have thus only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From identified a second mechanism of immunostimulation by nuclear self antigens in addition to the recently described triggering of TLR9 by chromatin-containing IC 4, 19, 20 . Given the important role of type I IFN and also IL-6 in human SLE 16 , the recognition of IC containing nuclear autoantigens by the endosomally localized TLRs 7 and 9, which leads to the induction of these cytokines via a common signalling pathway are attractive targets for therapeutic intervention: Pharmacological agents interfering with internalization of IC, endosomal maturation, binding of endogenous ligands to TLR7 and TLR9 or with the TLR7/9-specific signal tranduction pathway downstream of MyD88 should be promising candidates for immunotherapy of SLE . The study of Barrat et al. 42 , which was published during revision of this manuscript, shows that specific TLR7 antagonists inhibit IFN-α production in human PDC induced by IC formed with anti-RNP antibodies from SLE serum and apoptotic cell material, thus supporting our results obtained with purified U1snRNP/anti-Sm IC in murine PDC. FL-DC were sorted into PDC and conventional DC (> 97 % purity) as described in the methods section and stimulated with IC formed with U1snRNP (20 µg/ml) and anti-Sm antibody (100 µg/ml) for 36 hours. IFN-α and IL-6 were measured in the supernatants by ELISA. The mIFN-α ELISA kit from PBL Laboratories was used in these experiments.
Results of three independent experiments are shown. 
